The Pfizer-BioNTech "bivalent" shot protects against the most prevalent subvariants of Omicron, BA.4 and BA.5, and is the first approved for use in children between the ages of five and 11.
from CBC | Canada News https://ift.tt/3e9kyiG
Subscribe to:
Post Comments
(
Atom
)
Post a Comment
Note: Only a member of this blog may post a comment.